Buparlisib is a brain penetrable pan-PI3K inhibitor
2018 · Scientific Reports · 80 citations
https://doi.org/10.1038/s41598-018-29062-w
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
1.4K
Citations
17
h-index
19
i10-index
Levi C.M. Buil is an academic researcher from The Netherlands Cancer Institute. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Drug Transport and Resistance Mechanisms & FOXO transcription factor regulation. The author has an h-index of 17, co-authored 59 publications.
Click to start Chat